Full Press Release Details
SAN FRANCISCO, Nov. 01, 2023 (GLOBE NEWSWIRE) -- Olema Pharmaceuticals, Inc. (“Olema”, “Olema Oncology”, Nasdaq: OLMA), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of targeted therapies for women’s cancers, today announced that the Company will present at the following upcoming investor conferences in November:
Sean P. Bohen, M.D., Ph.D., President and Chief Executive Officer, will participate in a Fireside Chat at the Jefferies London Healthcare Conference at The Waldorf Hilton in London, UK, on Wednesday, November 15, 2023, at 12:30 p.m. GMT (7:30 a.m. ET).
Dr. Bohen will participate in a Fireside Chat at the 6th Annual Evercore ISI HealthCONx Conference in Miami, FL, on Wednesday, November 29, 2023, at 1:20 p.m. ET.
A live webcast of the Fireside Chats and any accompanying presentation materials will be available under the News & Events section of Olema’s investor relations website at ir.olema.com. The webcasts will be archived for at least 30 days.
About Olema Oncology
Geoffrey Mogilner, Vice President, Investor Relations and Communications